Abstract:Abstract Background Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. This disease is also a metabolic disorder because of the high prevalence of accompanying metabolic disturbances, which might pose a high long-term risk of diabetes. The aims of this study were to analyse the prevalence, prognosis, and risk factors of insulin resistance, impaired glucose tolerance, and diabetes in Chinese patients with polycystic ovary syndrome. Methods Data recorded from July, 1998, to December, 2015, of patients with polycystic ovary syndrome were extracted from the database of our department; patients without relevant data were excluded. Retrospective analysis of data was done from first visit versus last follow-up. Polycystic ovary syndrome was diagnosed according to the Rotterdam 2003 criteria. Homeostatic model assessment-insulin resistance was 2·14 mIU/L or higher and fasting insulin of 11·87 mIU/L or higher. Abnormal glucose metabolism included impaired glucose tolerance (IGT) and type 2 diabetes diagnosed according to the 2006 WHO criteria. Disease regression was patients with baseline insulin resistance reversed to non-insulin resistance, or those with baseline IGT reversed to non-IGT at follow up. Cox regression analysis was used for hazard ratios (HRs) of variables for prognosis of insulin resistance or abnormal glucose metabolism. The cutoff value of insulin or glucose concentration was set to the 75th percentile of the value in referential groups. Findings 2931 patient records with all the relevant data were selected for analysis. The mean patient age at baseline was 26 years (SD 5·28, range 12–43). The mean follow up time was 2·18 years (SD 2·25; range 0·1–16·0). There was no effect on prognosis of insulin resistance and abnormal glucose metabolism with clinical polycystic ovary syndrome phenotypes, however polycystic ovary syndrome decreased the risk of regression of insulin resistance being temporary (HR 0·30 [95% CI 0·09–0·94]). Baseline fasting insulin concentrations (HR 1·11 [95% CI 1·07–1·15]) and change in fasting insulin concentration from baseline to follow up (1·08 [1·06–1·11]) increased the risk of development of insulin resistance. Glucose concentration 1 h after oral glucose (HR 1·17 [95% CI 1·05–1·31]), glucose concentration after 2 h (1·48 [1·22–1·79]), change in 1 h glucose concentration from baseline (1·18 [1·12–1·25]), and change in 2 h glucose concentration from baseline (1·09 [1·04–1·15]) increased the risk of development of IGT. Glucose concentration after 1 h (HR 1·25 [95% CI 1·05–1·49]) and after 2 h (1·47 [1·19–1·81]), change in 1 h glucose concentration (1·22 [1·11–1·36]), and in 2 h (1·20 [1·08–1·32]) increased the risk of development of diabetes. Development of insulin resistance was more likely in patients with a baseline fasting insulin concentration of more than 8·82 mIU/L (p=0·001) or change in fasting insulin concentration of more than 2·91 mIU/L (p Interpretation Patients with polycystic ovary syndrome seem to have high prevalence of insulin resistance and abnormal glucose metabolism, whereas clinical polycystic ovary syndrome phenotypes seem to have no effect on the prognosis of insulin resistance and abnormal glucose metabolism. Subclinical insulin resistance, abnormal glucose metabolism, baseline impaired insulin or glucose concentrations, or worsening of these factors during follow-up seem to be predictors for development of insulin resistance or abnormal glucose metabolism in patients with polycystic ovary syndrome. Funding National Natural Science Foundation of China and Sun Yat-sen University.

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Association of Serum and Follicular Fluid Leptin Concentrations with Granulosa Cell Phosphorylated Signal Transducer and Activator of Transcription 3 Expression in Fertile Patients with Polycystic Ovarian Syndrome

Phoenixin-14 Concentrations Are Increased in Association with Luteinizing Hormone and Nesfatin-1 Concentrations in Women with Polycystic Ovary Syndrome.

Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome]

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Nesfatin-1, Dopamine, and NADPH levels in Infertile Women with Polycystic Ovary Syndrome: Is There a Relationship Between Their Levels and Metabolic and Hormonal Variables

Alteration of Sera Leptin and Relevant Factors in Patients with Polycystic Ovary Syndrome

THE FREQUENCY OF ELEVATED PROLACTIN LEVEL IN POLYCYSTIC OVARY SYNDROME WOMEN (PCOS) AND ITS' EFFECT ON PREGNANCY RATE

Serum Steroid Metabolome on the Day of Oocyte Retrieval in Women with Polycystic Ovarian Syndrome and Its Association with Pregnancy Outcome of in Vitro Fertilization.

Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications

Relationship between insulin resistance test and sex hormones in patients with polycystic ovary syndrome

Effect of Hyperinsulinemia on Leptin and Ghrelin Levels in Polycystic Ovarian Syndrome: A Meta-Analysis

Serum LBP is Associated with Insulin Resistance in Women with PCOS.

Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels

[Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors]

What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?

What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review

Serum adiponectin level is negatively related to insulin resistance in women with PCOS

Prognosis and risk factors of insulin resistance and abnormal glucose metabolism in patients with polycystic ovary syndrome: a single-centre, retrospective, database study